Human-derived hepatic in vitro models identify distinct anti-NASH efficacies of PPAR agonists

Joost Boeckmans; Matthias Rombaut; Alessandra Natale; Karolien Buyl; Vera Rogiers; Joery De Kock; Tamara Vanhaecke; Robim Rodrigues

Human-derived hepatic in vitro models identify distinct anti-NASH efficacies of PPAR agonists

Joost Boeckmans, Matthias Rombaut, Alessandra Natale, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim Rodrigues

Research output: Chapter in Book/Report/Conference proceeding › Meeting abstract (Book)

Original language	English
Title of host publication	Human-derived hepatic in vitro models identify distinct anti-NASH efficacies of PPAR agonists
Pages	1290A-1291A
Number of pages	2
Publication status	Published - 1 Oct 2019
Event	AASLD The Liver Meeting - Boston, United States Duration: 8 Nov 2019 → 12 Nov 2019

Conference

Conference	AASLD The Liver Meeting
Country/Territory	United States
City	Boston
Period	8/11/19 → 12/11/19

Cite this

@inbook{a0caa221487f4cfd8b33e162d2c57ac9,

title = "Human-derived hepatic in vitro models identify distinct anti-NASH efficacies of PPAR agonists",

author = "Joost Boeckmans and Matthias Rombaut and Alessandra Natale and Karolien Buyl and Vera Rogiers and {De Kock}, Joery and Tamara Vanhaecke and Robim Rodrigues",

year = "2019",

month = oct,

day = "1",

language = "English",

pages = "1290A--1291A",

booktitle = "Human-derived hepatic in vitro models identify distinct anti-NASH efficacies of PPAR agonists",

note = "AASLD The Liver Meeting ; Conference date: 08-11-2019 Through 12-11-2019",

}

Boeckmans, J , Rombaut, M, Natale, A, Buyl, K , Rogiers, V , De Kock, J , Vanhaecke, T & Rodrigues, R 2019, Human-derived hepatic in vitro models identify distinct anti-NASH efficacies of PPAR agonists. in Human-derived hepatic in vitro models identify distinct anti-NASH efficacies of PPAR agonists. pp. 1290A-1291A, AASLD The Liver Meeting, Boston, United States, 8/11/19.

Human-derived hepatic in vitro models identify distinct anti-NASH efficacies of PPAR agonists. / Boeckmans, Joost ; Rombaut, Matthias; Natale, Alessandra; Buyl, Karolien ; Rogiers, Vera ; De Kock, Joery ; Vanhaecke, Tamara ; Rodrigues, Robim.

Human-derived hepatic in vitro models identify distinct anti-NASH efficacies of PPAR agonists. 2019. p. 1290A-1291A.

Research output: Chapter in Book/Report/Conference proceeding › Meeting abstract (Book)

TY - CHAP

T1 - Human-derived hepatic in vitro models identify distinct anti-NASH efficacies of PPAR agonists

AU - Boeckmans, Joost

AU - Rombaut, Matthias

AU - Natale, Alessandra

AU - Buyl, Karolien

AU - Rogiers, Vera

AU - De Kock, Joery

AU - Vanhaecke, Tamara

AU - Rodrigues, Robim

PY - 2019/10/1

Y1 - 2019/10/1

M3 - Meeting abstract (Book)

SP - 1290A-1291A

BT - Human-derived hepatic in vitro models identify distinct anti-NASH efficacies of PPAR agonists

T2 - AASLD The Liver Meeting

Y2 - 8 November 2019 through 12 November 2019

ER -